Leadership, Planning and Evaluation
- Institution
- Icahn School of Medicine at Mount Sinai, NY
- Principal investigator
- Ramon E Parsons
- Funding
- $231K
- Duration
- 2015–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Part I: Planning and Evaluation It is understood by the senior leadership of The Tisch Cancer Institute (TCI) that continually assessing and reevaluating its objectives and processes is needed to ensure that resources are being strategically directed towards achieving the greatest benefit for cancer patients and research. To facilitate the strategic growth of the TCI at Mount Sinai, there has been a focus on utilizing both external experts and transparent internal processes to ensure a robust planning and evaluation process. These internal and external systems, including External Advisory Board meetings and internal retreats, planning and evaluation committees, and seminar series have allowed TCI leadership to develop a clearer roadmap for facilitating collaboration, optimizing investments and recruiting strategically. Part II: Senior Leadership The TCI senior leadership structure includes a Director, Deputy Director, and eleven Associate Directors. This senior leadership team is responsible for establishing a vision for the cancer center and for addressing the center’s overall goals, policies and operations.
LOADING MOONBASE SCORE
Questions for Icahn School of Medicine at Mount Sinai
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Icahn School of Medicine at Mount SinaiNot yet scored
The Tisch Cancer Institute - Cancer Center Support Grant
Ramon E Parsons · $3.1M · 2015–2030
- NIH · Icahn School of Medicine at Mount Sinai58
Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination
Joshua D Brody · $352K · 2024–2026
- NIH · Icahn School of Medicine at Mount Sinai58
Defining and targeting the lung cancer progenitor cell niche using a high-resolution, multi-omics approach
Daniel Charytonowicz · $55K · 2021–2026